We met up with Editorial Board member Bennie Jeng, who updated us on the exciting recent developments in dry eye disease and several new therapies are in development in the US. Dr Jeng talked about his experience with scleral contact lenses, which have proved particularly useful for very severe dry eye patients with GVHD and Stevens-Johnson disease in his clinic. There is still unmet need for patients with chronic severe dry eye disease patients, including access to scleral contact lenses and also recognising and understanding neuropathic pain. A better understanding of the mechanisms behind dry eye disease will help to develop new treatments.
1. What have been the most significant recent developments in the area of dry eye disease? (0:29)
2. Discuss the current unmet needs and/or the challenges you face when treating patients with dry eye disease. (1:53)
3. What developments are you most excited about in the area of dry eye disease over the next few years? (3:10)
4. Which presentations/data have interested you the most at this year’s WOC? (3:58)
Share this Video
Related Videos In Ocular Surface Disease
Marie Bannier-Hélaouët, ESCRS 2021: Lacrimal Gland Organoids
It was a pleasure to interview Marie Bannier-Hélaouët (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands) about her fascinating research into lachrymal gland organoids, which have great potential for the future treatment of lachrymal gland dysfunction. Questions What are the consequences of lachrymal gland dysfunction, and what have been the limitations in […]
Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!